Project Grant R35GM158075
Award Date
5/10/25
Completion Date
3/31/30
Dollars Obligated
$510K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Cincinnati, OH 45229, USA
Similar Awards
This $588,426 Project Grant award, provided by the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), aims to investigate how transcription factors efficiently locate and bind to specific DNA binding sites within the crowded nucleus of living cells. The project will employ advanced microscopy techniques to precisely track the 3D diffusion, DNA interactions, and target site discrimination of transcription factors involved in...
The federal Project Grant award of $136,661 provided by the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) supports the development of an innovative high-throughput reporter assay called PADIT-SEQ. This technology will be used to uncover fundamental principles governing transcription factor (TF) binding affinity and specificity to DNA sequences, with the goal of advancing the mechanistic understanding of gene regulation and how noncoding genetic variants...
The National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), awarded a $780,000 Project Grant to Oregon Health & Science University (OHSU) effective September 1, 2024 through July 31, 2029. The grant supports the development of innovative proteomic tools to study transcription factor-coregulator interactions and their role in gene regulation, cellular differentiation, and disease progression. Key objectives include...
The National Institute of General Medical Sciences (NIGMS) awarded a $415,252 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to The Regents of the University of California, Berkeley (UC Berkeley) for the project "PHYSICAL BIOLOGY OF TRANSCRIPTIONAL CONTROL IN EMBRYONIC DEVELOPMENT". The overarching goal is to leverage knowledge about regulatory regions and transcription factors to develop a predictive understanding of the developmental program...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $125,000 to the Dana-Farber Cancer Institute, Inc. to conduct research on transcriptional regulation by the ZMYM2-KDM1A-CoREST complex. The goal of this 2-year project (12/18/2024 - 11/30/2026) is to gain a structural understanding of how the ZMYM2 transcription factor recruits the KDM1A-CoREST chromatin modifying complex to...
The U.S. National Institute of General Medical Sciences (NIGMS) awarded a $667,480 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to St. Jude Children's Research Hospital Inc. on May 1, 2025. The grant supports a 5-year research project focused on studying the structural and functional dynamics of chromatin, which plays a critical role in cellular processes like gene expression, DNA replication, and cell differentiation. The research aims to advance the understanding...
This Project Grant award, valued at $172,499, was made by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The funding supports research to understand the role of histone deacetylases (HDACs) in zebrafish craniofacial development, as abnormal HDAC function is associated with various human craniofacial disorders. The key objectives are to investigate how individual HDACs, particularly HDAC1, interact with gene...
The National Human Genome Research Institute (NHGRI) awarded a $119,611 Project Grant under the Human Genome Research program (CFDA 93.172) to the Regents of the University of Michigan. The award period runs from August 29, 2024 to August 31, 2026. The grant will fund research to uncover regulatory networks controlled by transcription factors associated with monogenic diseases and decipher their involvement in driving complex disease phenotypes. The project aims to use advanced genomic...
This Project Grant award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) supports research to visualize the mechanisms at the intersection of chromatin, transcription, and epigenetics. The $1,525,500 award to Harvard Medical School aims to develop a combinatorial biochemical and structural approach called "Visual Biochemistry" that uses a fully reconstituted chromatin transcription system and time-resolved single-particle...
This federal Project Grant award from the National Institute of General Medical Sciences (CFDA 93.859 Biomedical Research and Research Training program) provides $1,031,008 to St. Jude Children's Research Hospital Inc. to conduct research on dissecting the contributions of phase separation to yeast transcription. The primary objectives are to: 1) examine how transcription factors, coactivators, and DNA phase separate together and how multivalent interactions and solubility contribute to their...